HomeNewsIndia'Totally fallacious': Centre rejects reports placing India's COVID-19 death toll at 2.7-3.3 million

'Totally fallacious': Centre rejects reports placing India's COVID-19 death toll at 2.7-3.3 million

The union health ministry said that it has been repeatedly advising states and union territories about recording of COVID-19 deaths in accordance with laid down guidelines

July 28, 2021 / 09:03 IST
Story continues below Advertisement
Representative image
Representative image

The Centre has rejected reports based on a "yet-to be peer-reviewed" study which claimed that at least 2.7 to 3.3 million COVID-19 deaths happened in India during the two waves, and termed it "totally fallacious".

It claimed that the government has been transparent in its approach to COVID-19 data management and ensured that a “robust system” of recording COVID-19 related deaths was in place in the country.

Story continues below Advertisement

In a statement issued on July 27, the Union Health Ministry said that “there have been some media reports, based on a yet-to be peer-reviewed study which was uploaded on MedRxiv recently, alleging that at least 2.7 to 3.3 million COVID-19 deaths happened during the two waves of COVID-19 in India, quoting three different databases ‘pointing towards at least 27 percent excess mortality over a year.’”

The report further "concludes" that India's COVID-19 death rate may be about 7-8 times higher than the officially reported toll and claims that "most of these additional deaths are likely to have been due to COVID-19", the ministry said in the statement.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show